Virtual Reality Technology to Enhance Conventional Rehabilitation Program: Results of a Single-Blind, Randomized, Controlled Pilot Study in Patients with Global Developmental Delay.
Carmela SettimoMaria Cristina De ColaErica PirontiRosalia MuratoreFabio Mauro GiambòAngelo AlitoMaria TresoldiMargherita La FauciCarmela De DomenicoEmanuela TripodiCaterina ImpallomeniAngelo QuartaroneFrancesca CucinottaPublished in: Journal of clinical medicine (2023)
Global developmental delay (GDD) is a complex disorder that requires multimodal treatment involving different developmental skills. The objective of this single-blind, randomized, controlled pilot study is to evaluate the feasibility and effectiveness of conventional rehabilitation programs integrated with the BTs-Nirvana virtual reality system. Patients with GDD aged 12 to 66 months were enrolled and treated for a 48-session cycle. Patients were randomized into two groups, (1) conventional treatment and (2) conventional treatment supplemented with the use of BTs-Nirvana, in a 1:1 ratio. Before and after treatments, areas of global development were tested with the Griffiths-III Mental Developmental Scale and the clinical indicator of global improvement were measured with the Clinical Global Impressions-Improvement (CGI-I). Feasibility was confirmed by the high retention rate. The experimental group presented a significantly improvement in General Quotient (GQ) after treatment (GQ, p = 0.02), and the effect of the two treatments was significantly different in both the GQ (t =2.44; p = 0.02) and the Foundations of Learning subscale (t =3.66; p < 0.01). The overall improvement was also confirmed by the CGI-I ( p = 0.03). According to these preliminary data, virtual reality can be considered a useful complementary tool to boost the effectiveness of conventional therapy in children with GDD.
Keyphrases
- virtual reality
- double blind
- open label
- randomized controlled trial
- systematic review
- phase iii
- newly diagnosed
- combination therapy
- young adults
- phase ii
- mental health
- stem cells
- ejection fraction
- public health
- clinical trial
- mesenchymal stem cells
- prognostic factors
- artificial intelligence
- chronic kidney disease
- chronic pain
- patient reported outcomes
- big data
- electronic health record
- transcranial direct current stimulation